Robert Fildes, Ph.D. (Chairman)
Dr. Fildes currently serves as President of SB2 Inc. Dr. Fildes has extensive experience in the biotechnology and pharmaceutical sector, including terms as President & CEO of Cetus Corporation, President of Biogen Inc., and Vice President of Operations for the Industrial Division of Bristol-Myers Squibb Company. He is currently a director on numerous boards of publicly and privately traded biotechnology companies. Dr. Fildes holds a D.C.C. degree in Microbial Biochemistry as well as a Ph.D. in Biochemical Genetics from the University of London.

Brian Barber, Ph.D.
Dr. Barber, currently Vice President, Global Ventures, University Health Network Development Corporation, is the former Chief Scientific Officer and Senior Vice President of Mojave Therapeutics Inc. Prior to joining Mojave, he was the Assistant Vice President of Immunology at Aventis Pasteur. Previously, Dr. Barber spent 20 years as a professor in the Department of Immunology, Faculty of Medicine at the University of Toronto, with cross-appointments to the University of Toronto's Institute of Medical Sciences and The Toronto Hospital's Division of Infectious Diseases. He received his Ph.D. from the Department of Medical Biophysics at the University of Toronto.

Pat Brady, M.B.A.
Mr. Brady is Vice President Investments, Life Sciences at Growthworks Capital. He joined Growthworks in 1998 with eight years of business and consulting experience with emerging companies. He was heavily involved in taking two companies public - one TSE listed and one listed on the NASDAQ. Mr. Brady has an M.B.A. from the University of Western Ontario. He sits on the boards of Celator Technologies Inc., NeuroMed Technologies, NeuroStream Technologies, Protiva Biotherapeutics, and Twinstrand Therapeutics.

Brenda Irwin, M.B.A.
Ms. Irwin is Director, Venture Capital for BDC Venture Capital. Her focus is on biotechnology investments. Her approach is largely the result of an initial career in the computer industry as marketing manager for a national distributor and her experience as science educator for the North York Board of Education. Eight years of professional leadership paved the way to becoming an investment professional. She participates as guest speaker at life sciences and high tech conferences. Ms. Irwin holds a Bachelor of Science degree in Human Biology and Biomedical Science from the University of Guelph and an M.B.A from the University of British Columbia.

Michael Cross, Ph.D. M.B.A.
Dr. Cross is a Senior Vice President and Portfolio Manager at JovInvestment Management Inc. Dr. Cross has considerable experience in the financial and operational management and executive governance of life science companies. He has been Chief Operating Officer of Viventia Biotech Inc. and Managing Director of a large cGMP contract manufacturing organization. Dr. Cross has also held a variety of senior positions at MDS and MDS Capital Corp, including Vice President of MDS Proteomics and Senior Investment Manager for MDS Capital. Before joining MDS, Dr. Cross spent seven years with the Department of National Defence, including serving as a Post-Doctoral Fellow with the Trauma and Physiology Group, Defence Research Agency in Toronto. Dr. Cross earned both a Ph.D. (Physiology) and an M.B.A. from the University of Toronto.